Trends in Medicare payments within the first year of cervical cancer diagnosis, 2010-2019
Menée à partir de données 2010-2019 des registres américains des cancers portant sur 2 147 patientes atteintes d'un cancer du col de l'utérus (âge supérieur ou égal à 65 ans), cette étude analyse l'évolution des coûts de santé pris en charge par le système Medicare
Assessing Medicare payment trends for cervical cancer care is important to mitigate the financial impact on Medicare. This multiyear cross-sectional study included 65 years and older cervical cancer patients in SEER registries diagnosed between 2010-2019 who had continuous Part A and B Medicare coverage at least 6 months prior to diagnosis and at least within the first year of diagnosis and were not enrolled in any Health Maintenance Organization in this duration. The main outcomes were trends in total and service-specific mean monthly Medicare payments within the first year of a cervical cancer diagnosis. This study included 2147 cervical cancer patients. The mean Medicare payments increased from $8,300 in 2010 to $8,520 in 2019, largely driven by a statistically significant increase in outpatient services costs, from $1,361 to $2,056 (AAPC=5.45, 95%CI 1.38-9.67, P-value=0.008). These findings highlight the need for policy actions to mitigate cervical-cancer-related financial impact on Medicare.
JNCI Cancer Spectrum , résumé 2025